PD-1/PD-L1 Inhibitors: The First Wave of Immuno-Oncology

Read also

• Datamonitor Healthcare: data analysis and insight

  Insight into NASH Pricing Strategies

  Explore the key hurdles to anticipating the initial and potential value of the NASH therapy market.

  Topics Drug approval Business strategies

  View white paper

• Datamonitor Healthcare: data analysis and insight

  Providing Coverage of the Commercial Topics in Q3

  The Commercial Solutions Strategy Suite from Informa Pharma Intelligence unites the power of vital tools to bring you actionable data, penetrating analysis, and a crucial industry view covering a variety of critical market aspects, allowing you to accurately Forecast, Analyze and Benchmark, and Understand the mark landscape.   

  Topics Drug approval Drug development landscape

  View Article

• Biomedtracker: follow the drug development process , Datamon...

  Key potential drug launches 2020

  Take a longer-term look at key late-stage drugs projected to hit the market in 2020, including new drug classes, major changes to standards of care, and/or large market opportunities across the wide range of indications covered by Biomedtracker and Datamonitor Healthcare.

  Topics Drug approval Drug review Drug development landscape

  View Infographic